BioNTech SE (BNTX)
85.04
-2.61
(-2.98%)
USD |
NASDAQ |
Nov 12, 16:00
84.66
-0.38
(-0.45%)
After-Hours: 06:39
BioNTech Profit Margin (Quarterly) : 14.31% for Sept. 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 14.31% |
| June 30, 2026 | -777.3% |
| March 31, 2026 | -450.4% |
| December 31, 2025 | -33.61% |
| September 30, 2025 | -1.89% |
| June 30, 2025 | -148.2% |
| March 31, 2025 | -227.5% |
| December 31, 2024 | 21.81% |
| September 30, 2024 | 15.91% |
| June 30, 2024 | -627.7% |
| March 31, 2024 | -168.0% |
| December 31, 2023 | 30.96% |
| September 30, 2023 | 17.94% |
| June 30, 2023 | -113.5% |
| Date | Value |
|---|---|
| March 31, 2023 | 39.33% |
| December 31, 2022 | 53.26% |
| September 30, 2022 | 51.57% |
| June 30, 2022 | 52.31% |
| March 31, 2022 | 58.02% |
| December 31, 2021 | 57.23% |
| September 30, 2021 | 52.75% |
| June 30, 2021 | 52.50% |
| March 31, 2021 | 55.07% |
| December 31, 2020 | |
| September 30, 2020 | -311.4% |
| June 30, 2020 | -211.4% |
| March 31, 2020 | -193.0% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Moderna, Inc. | 12.34% |
| Mereo BioPharma Group Plc | -732.9% |
| NuCana Plc | -- |
| Immatics NV | -1.10K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.09% |
| Return on Assets | -7.08% |
| Return on Invested Capital | -7.95% |
| Gross Profit Margin (Quarterly) | 71.11% |
| Operating Margin (Quarterly) | 12.89% |
| Return on Net Operating Assets | -39.36% |